The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Metformin as adjunct antituberculosis therapy
Abstract
The global burden of tuberculosis (TB) morbidity and mortality remains immense. A potential new approach to TB therapy is to augment protective host immune responses. We report that the antidiabetic drug metformin (MET) reduces the intracellular growth of Mycobacterium tuberculosis (Mtb) in an AMPK (adenosine monophosphate-activated protein kinase)-dependent manner. MET controls the growth of drug-resistant Mtb strains, increases production of mitochondrial reactive oxygen species, and facilitates phagosome-lysosome fusion. In Mtb-infected mice, use of MET ameliorated lung pathology, reduced chronic inflammation, and enhanced the specific immune response and the efficacy of conventional TB drugs. Moreover, in two separate human cohorts, MET treatment was associated with improved control of Mtb infection and decreased disease severity. Collectively, these data indicate that MET is a promising candidate host-adjunctive therapy for improving the effective treatment of TB.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For example, the anti-diabetic drug metformin is being utilized an immunomodulator for tuberculosis (Singhal et al., 2014).”
From Mitochondria in the Regulation of Innate and Adaptive Immunity (2015) · cites this paper as Singhal et al., 2014
Citations
Cites
Smyth, G. K. (2004) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1027 · Cited by 11,829
Bolstad, B. M., Irizarry, R. A., Åstrand, M., & Speed, T. P. (2003) · Bioinformatics · doi:10.1093/bioinformatics/19.2.185 · Cited by 8,328
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Kim, J., Kundu, M., Viollet, B., & Guan, K.-L. (2011) · Nature Cell Biology · doi:10.1038/ncb2152 · Cited by 7,227
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Mihaylova, M. M., & Shaw, R. J. (2011) · Nature Cell Biology · doi:10.1038/ncb2329 · Cited by 2,923
Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I., & Deretic, V. (2004) · Cell · doi:10.1016/j.cell.2004.11.038 · Cited by 2,252
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis
Berry, M. P. R., Graham, C. M., McNab, F. W., Xu, Z., Bloch, S. A. A., Oni, T., Wilkinson, K. A., Banchereau, R., Skinner, J., Wilkinson, R. J., et al. (2010) · Nature · doi:10.1038/nature09247 · Cited by 1,898
Cellular and molecular mechanisms of metformin: an overview
Viollet, B., Guigas, B., Garcia, N. S., Leclerc, J., Foretz, M., & Andreelli, F. (2012) · Clinical Science · doi:10.1042/cs20110386 · Cited by 1,720
Tlr signalling augments macrophage bactericidal activity through mitochondrial ros
West, A. P., Brodsky, I. E., Rahner, C., Woo, D. K., Erdjument-Bromage, H., Tempst, P., Walsh, M. C., Choi, Y., Shadel, G. S., & Ghosh, S. (2011) · Nature · doi:10.1038/nature09973 · Cited by 1,659
Cited by
Sorted by citations
Items 501–548 of 548
Dritsa, C., Hoffmann, S., Hulme, H., Lynch, C. P., Taylor, V., Burchmore, R., Cole, J., Goodwin, R. J. A., & Wall, D. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.04.15.648950
Johnstone, N., & Kadosh, K. C. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.05.07.652653
Wallis, R. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00163-0
Progress of single-cell sequencing technology in immunotherapy for tuberculosis
Fan, X., Chen, M., Wu, D., Lin, Y., & Chen, X. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1666630 · Cited by 1
Bomfim, C. C. B., Faivre, N., Benoist, T., Popis, M., Suire, B., Péricat, D., Sánchez-López, J. M., Aponte-Castillo, B. M., Näser, E., Viana, P., et al. (2026) · Microbiology Spectrum · doi:10.1128/spectrum.03729-25 · Cited by 1
Impact of Diabetes Mellitus in Tuberculosis (TB) Patients on TB Transmission
Huang, C.-C., Tan, Q., Becerra, M. C., Calderon, R. I., Contreras, C. C., Howard, N. C., Lecca, L. W., Jiménez, J., Madden, A. E., Yataco, R. M., et al. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf647 · Cited by 1
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735507
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735510
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735516
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735513
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735525
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735528
Heo, E., Kim, E., Jang, E. J., & Lee, C.-H. (2021) · Figshare · doi:10.6084/m9.figshare.16681475
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735522
Martin, D. E., Cadar, A. N., Panier, H. A., Torrance, B. L., Kuchel, G. A., & Bartley, J. M. (2023) · Figshare · doi:10.6084/m9.figshare.22735519
Navigating Tuberculosis in Pregnancy and Lactation: A Review of Maternal and Neonatal Considerations
Lima, T., Trigo, S., Silveira, E., Silva, G., & Domingues, S. (2026) · Diseases · doi:10.3390/diseases14030102
Samanta, A., Datta, N., Pramanik, M., Srinivasan, S., & Mahapatra, S. K. (2026) · Microbial Pathogenesis · doi:10.1016/j.micpath.2026.108456
Innovative platforms for drug discovery against mycobacteria: The success and challenges
Nitschke, J., Soldati, T., & Hanna, N. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-36518-8.00021-7
Putera, I., Nagtzaam, N. M. A., Swagemakers, S. M. A., de Steenwinkel, J. E. M., van Holten-Neelen, C., Nora, R. L. D., van der Spek, P. J., Rombach, S. M., van Hagen, P. M., & Dik, W. A. (2026) · Experimental Eye Research · doi:10.1016/j.exer.2026.110989
Impact des antibiotiques sur la réponse des macrophages humains : l'exemple de la bédaquiline
Giraud-Gatineau, A. (2019) · theses.fr (ABES) · doi:10.70675/e7540acaz0a22z4dcfz8d5azdf6f3232c4b4
Modulation de l'autophagie des macrophages : rôle des lipides de l'enveloppe
Bah, A. (2017) · theses.fr (ABES) · doi:10.70675/0170380fz0af5z4c02za7aezd5ac5153ffd8
Electron microscopy and diffraction study of metal-organic frameworks
Mansouri, A. (2023) · theses.fr (ABES) · doi:10.70675/62fccf4cz9e89z442dza4f7z85a56a0aeb4c
McCall, L.-I. (2026) · mSphere · doi:10.1128/msphere.00860-25
Immunomodulators as Therapy for Mycobacteria
Agrawal, F., & Maurya, A. K. (2026) · Springer eBooks · doi:10.1007/978-981-92-0256-0_15
Thong, P. M., Hu, T. H., Ooi, J. S. G., Loh, F. K., Lee, H., Bai, C., Chong, H. T., Chang, A. J. W., Choong, C. V., Galamay, L., et al. (2026) · medRxiv · doi:10.64898/2026.05.24.26353970
Satyam, S. M., Safaii, E., Shameer, I., Kumari, R., Prabhakar, S., Eltrabishi, M. T. Z. M., El‐Tanani, M., Rehman, A., & Abdelfattah, M. T. M. W. M. (2026) · Antibiotics · doi:10.3390/antibiotics15060583
Rongkard, P., Kronsteiner, B., Eckold, C., Chamnan, P., Chumseng, S., Ali, M., Hill, J. W., Abraham, P., Marchi, E., Limmathurotsakul, D., et al. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag286
Organelle interplay in host responses and mycobacterial resilience
Singh, S., Berdal, V., Deflandre, C., Chen, Z., Kremer, L., & Daher, W. (2026) · EMBO Reports · doi:10.1038/s44319-026-00836-y
He, Y., Xie, X., He, S., Li, S. B., Zhou, H., & Wei, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1859046
Kandlapalli, Y., Venkata, V. A., Thamineni, R., Chakali, V. M. K., Rajanandh, M. G., & Marthadu, S. (2026) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-026-01699-8
朱, 茜. (2026) · Hans Journal of Biomedicine · doi:10.12677/hjbm.2026.164073
Analysis of tuberculosis and multiple diseases as co-morbidities: a narrative review
Sun, Y., Zhou, K., Wang, W., Gao, Q., & Yan, L. (2026) · Annals of Medicine · doi:10.1080/07853890.2026.2702807
Niu, J., Zhang, P., Wei, Z., Zou, Y., & Wang, Z. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1896879
Hu, P., Lu, M., Cassandre, N. H., Chen, P., Liu, H., & Shi, Y. (2026) · Microbiological Research · doi:10.1016/j.micres.2026.128652
Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies
Silva, T., Aiello, A., Alonzi, T., Carvalho, M. A., Finger, V., Goletti, D., Hoffner, S., Kherabi, Y., Korábečný, J., Kulczyńska, J., et al. (2026) · Medicinal Research Reviews · doi:10.1002/med.70096
Ashaolu, J. O., & Some, S. Y. M. (2026) · All Life · doi:10.1080/26895293.2026.2710934
From integrated control to next-generation interventions against major hemoprotozoan parasites
Meryk, A., Hamed, O. R., Alkhudhayri, A. A., & Dkhil, M. A. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-48509-1.00008-2
Xu, M., & Peng, Z. (2026) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2026.1913094
Saha, S., Павловна, С. Н., Gizinger, O., Голікова, Н., Мухтаровна, А. А., Grushko, M., & Molchanova, M. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1916875
., H. I. S. (2026) · Research Square · doi:10.21203/rs.3.rs-10991918/v1
Yao, M., Pang, B., Tian, L., Wang, S., Huang, P., Dai, B., Kou, Z., & Zhang, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1912284
Pinnelli, V. B. K., THANGACHI, S. B., Jayashankar, C. A., Kandi, V., Manish, G. R., Sam, K. T., Raju, P. K. R. B., Sucharitha, A. S., Barman, A., Sainath, G., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1994202
Advances in host-directed therapies for tuberculosis
Shaku, M. T., & Bishai, W. R. (2026) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2026.2750203
Kou, Z., Han, J., Xue, Y., Fu, Y., Yi, Z., & Li, M. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.117598
BindingDB Entry 50018470: Repurposed drug candidates for antituberculosis therapy.
BindingDB (2024) · UC San Diego · doi:10.7270/q2zk5mvq
Macrophage-state heterogeneity as the basis for host-directed therapy in tuberculosis
Shariq, M., Ehtesham, N. Z., & Hasnain, S. E. (2026) · Frontiers in Tuberculosis · doi:10.3389/ftubr.2026.1969123
Metadata
- Authors
- Singhal, A., Jie, L., Kumar, P., Hong, G. S., Leow, M. K.-S., Paleja, B., Tsenova, L., Kurepina, N., Chen, J., Zolezzi, F., Kreiswirth, B., Poidinger, M., Chee, C., Kaplan, G., Wang, Y. T., & De Libero, G.
- Affiliations
- Agency for Science, Technology and Research (SG)
- Singapore Immunology Network, Agency for Science, Technology and Research (A*STAR), Singapore 138648, Singapore.
- Tan Tock Seng Hospital (SG)
- Rutgers, The State University of New Jersey (US)
- Corresponding author
- Singhal, Amit
- Kumar, Pavanish
- ORCID
- Venue
- Science Translational Medicine
- Published
- 2014-11-19
- Volume
- 6
- Issue
- 263
- Pages
- 263ra159-263ra159
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2105296171
- Cited by
- 547
- References
- 49
- Citations by year
- 2026: 39 · 2025: 44 · 2024: 44 · 2023: 35 · 2022: 51 · 2021: 64 · 2020: 71 · 2019: 53 · 2018: 51 · 2017: 33 · 2016: 35 · 2015: 24 · 2014: 2
- FWCI
- 22.03
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science Translational Medicine (publishedVersion)
- PubMed (publishedVersion)
- National University of Singapore (submittedVersion)
- edoc (University of Basel) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- metformin, tuberculosis, Mycobacterium tuberculosis, AMPK, host-directed therapy, drug-resistant tuberculosis, reactive oxygen species, phagosome-lysosome fusion, host immune response, chronic inflammation
- MeSH terms
- Humans, Metformin, Microbial Sensitivity Tests, Mycobacterium tuberculosis, Tuberculosis, Reactive Oxygen Species
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
